MLYS Mineralys Therapeutics, Inc.

NASDAQ
$18.18

Mineralys Therapeutics, Inc. (MLYS) Earnings News

Earnings press releases, previews and reviews for Mineralys Therapeutics, Inc. (MLYS), newest first. Our most recent is preview: Mineralys Heads Into Final Pre-PDUFA Report With Launch Readiness and Cash Burn in Focus.